Introduction: Angioimmunoblastic T Cell Lymphoma (AITL) is a well-recognized subtype of peripheral T cell lymphoma. It occurs predominantly in the lymph nodes with presence of systemic symptoms and carries a dismal prognosis. AITL accounts for about 1% -2% of all cases of non-Hodgkin lymphoma. Case presentation: A 59-year-old gentleman of Chinese ethnicity with no prior medical illness presented to Tengku Ampuan Afzan Hospital with a two-month history of fever, anorexia, unintentional weight loss and generalized lymphadenopathies. Physical examination revealed diffuse lymphadenopathies involving the cervical, axillary and inguinal regions bilaterally. He had hepatosplenomegaly. An excisional biopsy of the cervical and inguinal lymph nodes was compatible with AITL. The bone marrow biopsy demonstrated disease infiltration. He was treated with 6 cycles of Etoposide-CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) induction chemotherapy followed by consolidation high dose therapy-autologous stem cell transplant (HDT-ASCT). He achieved complete remission on 18-Fluorodeoxyglucose Positron Emission Tomography (18-FDG-PET) imaging. His bone marrow biopsy showed disease clearance. Conclusion: The diagnosis of AITL remains challenging and often poses a dilemma to clinicians and lymphoma pathologists. The natural history of AITL remains very variable with many of them relapsing subsequently despite achieving prior complete remission.
. AITL occurs predominantly in the lymph nodes with the presence of systemic symptoms and carries a dismal prognosis. AITL accounts for about 1% -2% of all cases of non Hodgkin lymphoma [2] . 20% of cases of Peripheral T Cell Lymphoma (PTCL) are attributed to AITL annually [2] . The median age of diagnosis is 65 and AITL does not have a clear gender predisposition. The highest incidence rate of AITL is seen in Europe (28.7%) [3] . Epstein Barr Virus is known to have a strong association with AITL with 80% -95% of biopsies revealing Epstein Barr Virus infection on in-situ hybridization (EBERish) [4] . Almost 70% of patients with AITL have bone marrow involvement at diagnosis and most of them present at advanced stage [4] . The main objective of reporting this case is to share with the medical fraternity of a rare presentation of Angioimmunoblastic T Cell Lymphoma which has a variable natural history. core biopsies revealed a high false negative rate and a low negative predictive value [6] .
Case Presentation
The cell of origin for AITL is the follicular helper T cells (T FH ), an effector T Cell subset [7] . High power view microscopy of the lymph node demonstrates abundant immunoblasts, B cells, plasma cells, eosinophils, epithelioid cells, follicular dendritic cells and high endothelial venules [7] .
Neoplastic T cells in AITL frequently express CXCL13, BCL-6, CD40L, CD 200 and ICOS with 95% of AITL cases show enhanced expression of at least one of the following markers: SLAM-associated protein, programmed death-1 (PD-1) and c-Maf [8] .
There is no gold standard chemotherapy for AITL. Anthracycline-based chemotherapy protocols such as CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) appears to be the frontline regimen in many centers but the outcomes are often disappointing. CHOP carries a complete response (CR) rate of 39% in an upfront setting and specifically in AITL, a 53% CR rate [9] . The addition of etoposide to CHOP in AITL demonstrates promise as an induction regimen with high overall response rates (ORR) at 82% and a CR rate of 51% [10] . High dose therapy followed by autologous stem cell transplant as upfront consolidation has become an increasingly used modality in those who are chemosensitive [10] . A large retrospective analysis from the European Group for Blood and Marrow Transplantation (EBMT) reported an improved response rate of 76% and a 5-year OS of 44% in AITL.
Conclusion
The diagnosis of AITL remains challenging and often poses a dilemma to clinicians and lymphoma pathologists. Obtaining an excision biopsy often provides good yield thus hastening the diagnosis of AITL. The natural history of AITL remains very variable and carries a poor prognosis with many of them relapsing subsequently despite achieving prior complete remission.
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